Lyell Immunopharma
0 followers
‌
Lyell is an immuno-oncology company dedicated to reprogramming T cells to achieve curative therapies for solid tumors. The company takes a deliberate approach to solving what it believes to be the major barriers to successful adoptive T cell therapy: T cell exhaustion and loss of durable stemness, w... Read more
Org chart
Lynn Seely
President & Chief Executive Officer
Lynn Seely
Collapse
Tina Albertson
Chief Medical Officer & Head of Development
Stephen Hill
Chief Operating Officer
Gary Lee
Chief Scientific Officer
Charles Newton
Chief Financial Officer
Matthew Lang
Chief Business And Legal Officer
Ellen Rose
Senior Vice President, Communications & Investor Relations
Joseph Maguire
Head Of GMP Automation And Data
Eric Hoffmann
Staff Software Engineer, Devsecops
Erik Green
Principal, Cloud Engineering
Julie Urvater
Senior Director, Intellectual Property
Stasiu Nowak
Director, Intellectual Property
Manjit Dokal
Senior Director, Enterprise Applications And Data
Chris Michon
Associate Director, IT Operations
Danielle Kulman
Associate Director, Total Rewards
Rick Watt
Senior Director Total Rewards
Julie Jeffery
Associate Director | Talent Acquisition
Karen Duffy-Simons
Director, Talent Practice Leader
Vonnie Vo
Associate Director, Payroll & A/p
Kimberly Henson
Contracts Consultant
